These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16889570)

  • 21. Asialoerythropoietin has strong renoprotective effects against ischemia-reperfusion injury in a murine model.
    Okada T; Sawada T; Kubota K
    Transplantation; 2007 Aug; 84(4):504-10. PubMed ID: 17713435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical and clinical effects of erythropoietin in the management of anaemia in patients with non-small cell lung cancer.
    Dempke W
    Anticancer Res; 2007; 27(4A):1745-57. PubMed ID: 17649769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Erythropoietin - state of science].
    Schöffel N; Börger JA; Quarcoo D; Scutaru C; Groneberg DA
    Sportverletz Sportschaden; 2008 Dec; 22(4):201-6. PubMed ID: 19085770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The cardiorenal syndrome and erythropoietin].
    Kes P; Basić-Jukić N; Jurić I; Basić-Kes V
    Acta Med Croatica; 2008; 62 Suppl 1():21-31. PubMed ID: 18578329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythropoietin and hypertension.
    Nowicki M
    J Hum Hypertens; 1995 Feb; 9(2):81-8. PubMed ID: 7752179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythropoietin and the heart: facts and perspectives.
    Mastromarino V; Volpe M; Musumeci MB; Autore C; Conti E
    Clin Sci (Lond); 2011 Jan; 120(2):51-63. PubMed ID: 20929439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Erythropoietin: a new perspective in cardiovascular therapy].
    Raddino R; Robba D; Caretta G; Bonadei I; Teli M; Zanini G; Madureri A; Vizzardi E; Dei Cas L
    Monaldi Arch Chest Dis; 2008 Dec; 70(4):206-13. PubMed ID: 19263796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythropoiesis stimulation in acute ischemic syndromes.
    Ruifrok WP; Lipsic E; de Boer RA; van Gilst WH; van Veldhuisen DJ
    Heart Fail Clin; 2010 Jul; 6(3):313-21. PubMed ID: 20630406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythropoietin and the heart: physiological effects and the therapeutic perspective.
    Sanchis-Gomar F; Garcia-Gimenez JL; Pareja-Galeano H; Romagnoli M; Perez-Quilis C; Lippi G
    Int J Cardiol; 2014 Feb; 171(2):116-25. PubMed ID: 24377712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human erythropoietin reduces epithelial cell apoptosis and attenuates bleomycin-induced pneumonitis in mice.
    Yoshimi M; Maeyama T; Yamada M; Hamada N; Fukumoto J; Kawaguchi T; Kuwano K; Nakanishi Y
    Respirology; 2008 Sep; 13(5):639-45. PubMed ID: 18713087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular effects of erythropoietin: anemia and beyond.
    Guglin ME; Koul D
    Cardiol Rev; 2006; 14(4):200-4. PubMed ID: 16788333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Erythropoietin: indications and measurement].
    Klein E; Georges A; Brossaud J; Bosredon Kd; Bordenave L; Corcuff JB
    Ann Biol Clin (Paris); 2009; 67(5):505-15. PubMed ID: 19789122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human erythropoietin prevents lipopolysaccharide-induced vascular hyporeactivity in the rat.
    di Villa Bianca Rd; Sorrentino R; Mitidieri E; Marzocco S; Autore G; Thiemermann C; Pinto A; Sorrentino R
    Shock; 2009 May; 31(5):529-34. PubMed ID: 18838949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EPO: renoprotection beyond anemia correction.
    Fliser D; Bahlmann FH; Haller H
    Pediatr Nephrol; 2006 Dec; 21(12):1785-9. PubMed ID: 16957890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The erythropoietin receptor in normal and cancer tissues.
    Jelkmann W; Bohlius J; Hallek M; Sytkowski AJ
    Crit Rev Oncol Hematol; 2008 Jul; 67(1):39-61. PubMed ID: 18434185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythropoietin: physiology and clinical experience.
    Varet B; Casadevall N; Lacombe C; Nayeaux P
    Semin Hematol; 1990 Jul; 27(3 Suppl 3):25-31. PubMed ID: 2198661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythropoietin administration protects against functional impairment and cell death after ischaemic renal injury in pigs.
    Forman CJ; Johnson DW; Nicol DL
    BJU Int; 2007 Jan; 99(1):162-5. PubMed ID: 16956351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of erythropoietin receptor and in vitro functional effects of epoetins in B-cell malignancies.
    Kokhaei P; Abdalla AO; Hansson L; Mikaelsson E; Kubbies M; Haselbeck A; Jernberg-Wiklund H; Mellstedt H; Osterborg A
    Clin Cancer Res; 2007 Jun; 13(12):3536-44. PubMed ID: 17575216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythropoietin and acute renal failure.
    Sharples EJ; Yaqoob MM
    Semin Nephrol; 2006 Jul; 26(4):325-31. PubMed ID: 16949472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythropoietin in experimental acute renal failure.
    Sharples EJ; Yaqoob MM
    Nephron Exp Nephrol; 2006; 104(3):e83-8. PubMed ID: 16837817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.